Custodianship - Reinstatement - Mergers - R/S Denied

[Magnum7419]

thank god we missed that one :) FYI you might want to correct your flyer on toxic notes IMHO.................."Curt Kramer"

[Golden Cross]

$TWOH: .0029 You miss beginning of $DCGD $TSNP $FITY?? HERE GOES $TWOH

[Hestheman47]

Not that I know of. There used to be a site that I subscribed to that brought up custodianship filings very quickly.......after the amendments to 15c2-11 in 2020 there were significantly less custodianship filings. I let my subscription lapse, and that site is no longer taking new members. I think it is because of the decline. Hopefully, with a new SEC chairman coming, we will see a rollback in these regulations. I was not able to read te entire article, but I like the headline https://www.cnbc.com/2024/11/15/bank-of-america-says-trumps-win-will-unlock-small-cap-merger-deals.html we could see a revival of small cap mergers in the near future. However, we need a free and fair market to buy shares in them when we see those opportunities (like it was before 2020). They need to open up the expert market to retail and allow brokers to quote those stocks and make transactions with retail. Or nix the expert market and move those 3k stocks to OTCID or Pink Current where we can trade them. From what I hear, the new SEC chairman is anti regulation. We will soon find out if that is true. Restricting trades on certain stocks and removing the buy button is not a free and fair market.

[Nealio]

I appreciate that informative reply. Is there a summary of Total Custodianship Changes/Reverse Mergers...compared year to year? I'd be curious to see the changes in last 5-6 yrs.

[Hestheman47]

I think rule 15c2-11 and the expert market has something to do with that. After that was implemented, it seems we saw shell custodians go missing. Because of new rules, custodians have less time to find a viable company for their shell and could lose their investment. For traders like you and I, we may not be able to get in on the bottom floor of a shell play if it is listed on the expert market. I am hoping that the new SEC chair, who is a crypto buff and known to be in favor of deregulation, will roll back the rules we saw implemented in 2019-2020 and the OTC will see a return to it's glory days. The OTC has been dead for years now and if it is to return, the new SEC chair must put things back the way they were. The OTC market was always intended to be the wild west, not regulated like the big boards. We liked it that way. We understood the risk and reward. Like crypto, the more opportunities the better.

[Hestheman47]

Good news for the OTC......July 2025 could see a RESURGENCE of custodianship/reverse merger plays https://blog.otcmarkets.com/2024/10/14/the-evolution-of-the-otc-market-introducing-otcid/?utm_campaign=OTCID&utm_source=twitter&utm_medium=social&utm_content=1729020462

[pauljack13]

Waiting on $ZHUD

[Nealio]

Do OTC shells still get acquired? Seems this and other related boards have gone very quiet.

[Golden Cross]

$AVOI Early here--8K Change of control filed 4-24... I think we see something very nice come into AVOI... New owner has million$ and many business contacts... I don't think they spent this kind of money to let it sit for long...

Bet we find out what is coming in soon...

[WHITTENHALLJR]

Big 30k bid at .3 Lift-off >>>>$$$ get in or miss the run to $6.00

[Welcome2Pinkyland]

Sweet

[WHITTENHALLJR]

Awesome I’ll be on the bid in the morning

$CLHI

[Welcome2Pinkyland]

im ready

[WHITTENHALLJR]

Still in looking as if $CLHI may go soon

[Plowmaster]

And even better! $BWVI the future just keeps on getting better and better wow

https://psychedelicalpha.com/news/breaking-morgan-stanley-publishes-optimistic-report-on-psychedelics

[Plowmaster]

$BWVI Just keeps getting better

We're honored to be named among some of the top psychedelic companies on @USNewsMoney's List of 7 Psychedelic Stocks to Watch. #mentalhealth #biotechnewshttps://t.co/40Rzfo0A0Y

— Psycheceutical (@psycheceutical) August 1, 2022

[Plowmaster]

$BWVI had a major L2 shift last week and making its moves back up. Ticker Change from FINRA any day and post that, news roll out and investors coming in, expecting significant uptick over next few weeks. Low locked float, very primed and great scenario

Well worth solid DD

$BWVI

[daman45]

Do you guys live in Canada? Are you able to buy it right now on the expert market? If not, why should anyone care about this stock? I remember the gold 'ol days when people who did their DD could capitalize on filings and get in on the bottom floor of plays like this and make money. The new SEC rules have killed it now. So again, who should care? This market is dead.

[Mavlo77]

$ilim for the win! I’ll be watching this one closely this week.

[Golden Cross]

ThanX... Nice move underway

[TB]

$ZONX That was an old case. This one was closed. New here: granted

new : A-22-850895-P Result Granted

https://www.clarkcountycourts.us/Portal/Case/CaseDetail?eid=C1RdKQKV4SUqdKhv3EBDIQ2&tabIndex=3


old : A-21-834698-P

https://www.clarkcountycourts.us/Portal/Case/CaseDetail?eid=l5bJa3BlYXNlvx8CyBHNMA2&tabIndex=3

[TB]

$ZONX Result Granted https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168922050

[Mavlo77]

iPhone, iMac, ilst, and ilim. I’m ready.

[Golden Cross]

$ILST change of control completed yesterday... Should be hearing who bought the ILST shell within days now...

New owners paid $305K for it so I believe they have cash on hand

Waiting on news now... Load and hold

.0055 Now --- Targets .01/.02/.05+

[Plowmaster]

$BWVI HUGE Psycheceutical Brings on Kevin Harrington, the original shark from Shark Tank as Investor and Strategic Advisor

Psycheceutical Brings on Original Shark from 'Shark Tank,' Kevin Harrington, as Investor and Strategic Advisor


May 10, 2022 (PRNewswire via COMTEX) -- PR Newswire

MIAMI, May 10, 2022

Famed entrepreneur excited about the company's development of psychedelic pharmaceutical medicines to treat the widespread mental health crisis

MIAMI, May 10, 2022 /PRNewswire/ -- Psycheceutical, Inc. (a wholly owned subsidiary of Psycheceutical Bioscience, Inc. (OTC: BWVI), a biopharmaceutical company dedicated to the development and commercialization of psychedelic medicines, today announced the addition of original Shark Tank entrepreneur Kevin Harrington as the corporation's newest investor and strategic advisor. Harrington joins Psycheceutical to provide expertise on the strategy, direction, and execution of the company's growth and development in pursuit of its mission to accelerate the research, availability, and delivery of safer and more effective psychedelic pharmaceutical medicines.

"The world is undergoing an unprecedented mental health crisis. We all know someone who is suffering from depression, anxiety, or addiction. What we've been doing isn't working," said Harrington. "We need a different approach to treatment, and psychedelic medicines have shown incredible promise where conventional medicines have failed. It seems clear to me that psychedelics are the future of mental health treatment, but they need to be delivered safely like pharmaceutical medicines, which is why I'm so excited about Psycheceutical."

"I've been watching the emerging psychedelic medicine industry and looking for investment opportunities. I chose to invest in and join Psycheceutical because of their patented next-generation delivery technologies, designed to increase the safety and efficacy of psychedelic compounds without the hallucinogenic side effects. As an entrepreneur who is trying to help people and make a positive impact with my investments, these kinds of opportunities don't come up that often: real solutions to help alleviate real suffering for millions of people," added Harrington.

As an original shark on the hit TV show Shark Tank, the creator of the infomercial, and pioneer of the As Seen on TV brand, Kevin Harrington's business ventures have launched more than 1,000 products and produced well over $6 billion in global sales. More than 20 of Harrington's companies have each topped $100 million in revenue.

"We are thrilled to have Kevin Harrington on board as an investor and advisor, and we greatly appreciate his passion for mental health and for bringing awareness to cutting-edge psychedelic treatments as a way to solve this mental health epidemic," said Chad Harman, CEO of Psycheceutical. "Kevin has worked with some of the world's biggest celebrities and launched some of the best-selling campaigns in history. His expertise is invaluable as we execute our mission to facilitate the widespread availability of safer and more effective psychedelic pharmaceutical medicines."

https://www.marketwatch.com/press-release/psycheceutical-brings-on-original-shark-from-shark-tank-kevin-harrington-as-investor-and-strategic-advisor-2022-05-10?mod=mw_quote_news_seemore

[Plowmaster]

$BWVI News, remember this hasn't even started. This is heading to the ticker change and then the show begins. Leading up to it though, very exciting!

Psycheceutical Announces Julian Bailes, M.D. as Principal Medical Advisor


MIAMI, March 1, 2022 /PRNewswire via COMTEX/ -- MIAMI, March 1, 2022 /PRNewswire/ -- Psycheceutical, Inc. (a wholly-owned subsidiary of Blue Water Ventures International, Inc. (OTC: BWVI), a bioscience company dedicated to the development and commercialization of psychedelic medicines, today announced the addition of Dr. Julian Bailes as Principal Medical Advisor. Bailes will participate in the strategy, direction, and execution of the company's clinical and technology development in pursuit of its mission to accelerate the research, availability, and delivery of safe and effective psychedelic pharmaceutical medicines.

Bailes is a recognized leader in the field of neurosurgery and the impact of brain injury on brain function. His expertise in the field of chronic traumatic encephalopathy (CTE) is showcased in the 2015 film "Concussion," starring Will Smith, where Bailes is portrayed by actor Alec Baldwin. CTE is a progressive degenerative disease found in individuals who have sustained repetitive head impacts, multiple concussions or other forms of head injury. His expertise includes cranial surgery, traumatic brain injury, PTSD, and CTE.

Bailes is the chairman of the Department of Neurosurgery at the NorthShore University Health System and co-director of the NorthShore Neurological Institute, both located in Evanston, Ill. He also serves as Chairman of the Pop Warner Football Medical Advisory Committee. As Principal Medical Advisor for Psycheceutical, Bailes will be a key advisor to both the senior management team and the board of directors, which determine and oversee the company's drug development activities.

"Dr. Bailes brings critical knowledge of the central nervous system and a shared mission of making vital psychedelic therapies available to the people who need them as quickly and safely as possible," said Chad Harman, CEO, Psycheceutical. "His depth of knowledge and proven leadership track record will be essential to bringing our patented psychedelic delivery technologies to market and, ultimately, strengthening the broader psychedelic pharmaceutical industry as a whole."

With more than 300 scientific publications concerning various aspects of neurosurgery and editorial assignments for a number of medical journals, Dr. Bailes' reputation in the field of neurosurgery will bring further academic expertise to the emerging field of psychedelic medicine.


"The psychedelic pharmaceutical industry is primed for technological improvements in how these powerful medicines are developed and delivered to patients," commented Dr. Bailes. "I am excited to be working with a company at the forefront of helping bring these products to market in a safe, efficient way."

About Psycheceutical, Inc.

Psycheceutical, Inc. is the wholly-owned subsidiary of Blue Water Ventures International, Inc. (OTC: BWVI). Psycheceutical is developing cutting-edge delivery technologies to support safe and effective psychedelic pharmaceutical medicines. Powered by a team with more than 100 years' combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry, Psycheceutical is on a mission to bring safety and efficacy to psychedelic compounds. Learn more at Psycheceutical.com.

Forward-Looking Statements:

Certain statements in this news release related to the Company constitute "forward-looking information" within the meaning of applicable securities laws and are prospective in nature. Forward-looking information is not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These uncertainties include, but are not limited to, (i) general market growth for and acceptance of psychedelic-inspired medicines, (ii) capital and credit availability and market volatility, (iii) general economic conditions, (iv) governmental approvals and compliance with regulations, (v) product research and development and clinical trial risks, (vi) incorrect underlying assumptions, and (vii) our future business development, results of operations, and financial condition. These statements generally can be identified using forward-looking words such as "will," "may," "should," "could," "intend," "estimate," "plan," "anticipate," "expect," "believe," "potential" or "continue," or the negative thereof or similar variations. All information provided in this press release is as of the date of this press release, and we undertake no duty to update such information, except as required under applicable law.

Contact:
Dianne Gleason
[e-mail]


https://www.marketwatch.com/press-release/psycheceutical-announces-julian-bailes-md-as-principal-medical-advisor-2022-03-01?mod=mw_quote_news_seemore

[Welcome2Pinkyland]

i'm in for the next merger try. $CLHI

[Plowmaster]

$BWVI Psycheceutical players. I've posted before on the RM for
$BWVI w/ psycheceutical.com/

Merger completed last month ands progressing well. First SEC filing is in, along with the updated name in the NVSOS. (You won't find the old company name anywhere.) I encourage you to review the investor deck, see what the company is all about. If not interested, at least you know about other players in the space and what they up to. It is good DD as part of any psycheceutical companies you invest in.

Psycheceutical doing the corporate change over right now, ticker will get changed after final regulatory fillings (rubber stamp back end of the RM process) but then investor roadshow and all news start coming out. They have been a private company in stealth mode and going to unleash! This is just getting started.

Great product and team, serious incoming player imo and we are still very undervalued (Again READ the investor deck) and undiscovered at this point. But imo the future looks significantly optimistic.

Lots of you tube videos on Zappy as well, just search.

Its good DD either way, knowledge is power.....

psycheceutical.com/investors/

[Plowmaster]

$BWVI Its DONE! Definitive done! Like I have been saying for a few months! The future looks incredibly bright!

Tweet: @Psycheceutical Inc., today announced the company has been fully acquired by Blue Water Ventures International, Inc. (OTCPK: $BWVI)." Read more from today's announcement:

Psycheceutical Completes Acquisition by Blue Water Ventures International

Press Release | 01/20/2022
Miami, FL, Jan. 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Psycheceutical, Inc., a biotechnology company dedicated to the development and commercialization of psychedelic medicines, today announced the company has been fully acquired by Blue Water Ventures International, Inc. (OTCPK: BWVI).

“We are thrilled that this deal has closed and that Psycheceutical is now a wholly-owned subsidiary of a publicly-listed company and has secured important near-term capital to pursue our growth plans,” commented Psycheceutical CEO Chad Harman. “We will immediately begin the next steps of our growth strategy as we work to bring our revolutionary psychedelic drug delivery technologies to the market, starting with initial clinical trials.”

BWVI acquired Psycheceutical, Inc. by way of a merger, resulting in Psycheceutical becoming a wholly-owned subsidiary of BWVI. Now that the acquisition has occurred, BWVI intends to cease its previous business activities and the company will focus solely on psychedelic drug development. Once regulatory approvals have been received, the company will consummate related corporate actions, including a name and symbol change.

About Psycheceutical, Inc.
Psycheceutical, Inc. is seeking to develop cutting-edge delivery technologies for safe and effective psychedelic pharmaceutical medicines. Powered by a team with more than 100 years' combined experience in development, regulatory approval processes and commercialization across the pharmaceutical industry, Psycheceutical is on a mission to bring safety and efficacy to psychedelic compounds. Learn more at Psycheceutical.com.

Jeffrey Bahnsen
407-808-5700
[e-mail]

"@Psycheceutical, Inc., today announced the company has been fully acquired by Blue Water Ventures International, Inc. (OTCPK: $BWVI)."
Read more from today's announcement: https://t.co/mAnSg6wHQr pic.twitter.com/QKORds18u9

— Psycheceutical (@psycheceutical) January 20, 2022

https://www.otcmarkets.com/stock/BWVI/news/Psycheceutical-Completes-Acquisition-by-Blue-Water-Ventures-International?id=340012

Future is quite bright!

$BWVI

[Plowmaster]

$BWVI Up 350% since started covering here, and LOTS of room to run.... Just saying! You REALLY should be doing DD here!

RM definitive with Psycheceutical.com to drop any day! This week looks very promising! The DD continues to line up for the RM Definitive! DD supports x10 ROI

Be sure to do your own DD and verify everything!

The OS was just updated. The commons changed only a tiny bit, like 350k, but the restricted shares went up 35M, this is in essence imo the control block for psycheceutical management.

Just that last bit, the definitive dropping! And the conference would be an awesome place to mention the new pubco!
Lastest News:

Zappy, Chief Visionary Officer, and Kaia Roman, V.P. of Strategy & Communications, will be presenting at Cannadelic Miami, the world’s first cannabis & psychedelics expo, on Feb 5-6, 2022:

flmjexpo.com/

Everything that has come before this:

10-7 NV Biz Reg updated: https://esos.nv.gov/EntitySearch/OnlineEntitySearch

11-3 LOI IN:
https://www.otcmarkets.com/stock/BWVI/news/Blue-Water-Ventures-International-Inc-Signs-Non-Binding-Letter-of-Intent-to-Acquire-Psycheceutical-Inc?id=328933

11-4 COC IN:
https://www.otcmarkets.com/otcapi/company/financial-report/309560/content

The CoC brought in management whose history is facilitating RM's. They are not here to run the old company, the are here for the shell to a new pubco with great potential, great tech, great industry.

SS: 106,634,589 Restricted 82,071,048 (Up ~35M on 1/13/22 Unrestricted 24,563,541 (only like 350k up!) float: 24,163,541
https://www.otcmarkets.com/stock/BWVI/security

Now just waiting for definitive to hit, and it is looking very good for the near future!

Checking a comparison of other companies in the industry to see what kind of evaluation we should get post merger. Plenty will depend on what kind of news they put out, but if we look at the average of all market caps and what BWVI will be post RM, its already x10. Check the reference chart below.

[Plowmaster]

$BWVI even higher now, Looks optimistic to drop next week! Boomage x5-20 coming IMO from all the DD available and verifiable.

Based on SS just Updated 1/13, restricted gone up. This would only be for the RM, oh man, looking so good! Do your DD!!!

0.5950
Pink Current, AS: 300M, OS: 106M, US: 24M

Outstanding Shares Updated:
70,844,180 (2021-10-11)
106,634,589 (2022-01-13)
Difference: +50.5% (+35M)

Restricted Shares Updated:
46,630,639 (2021-10-11)
82,071,048 (2022-01-13)
Difference: +76.0% (+35M)

Unrestricted Shares Updated:
24,213,541 (2021-10-11)
24,563,541 (2022-01-13)
Difference: +1.4% (+350K)

Chart, OTC Profile, Twitter, @otcupdates

Update: 2022-01-13 23:17:28 (UTC)

[mick]

consolidating some $lithium & graphene $igex

[Welcome2Pinkyland]

$IGEX for the win $$

[mick]

YES I LIKE $IGEX LOTS THE MINERAL COMPANY

[Welcome2Pinkyland]

time tells all

[mick]

YES ON $ACCR LAST IS GOING E.V. ????? METAVERSE ????? DIGITAL CURRENCY ?????

[Welcome2Pinkyland]

hi mick. i haven't heard anything

[mick]

ANY UPDATE FER $ACCR ?????

[Plowmaster]

$BWVI .6250 now, just saying if been following my posts here....

Do your DD!

[Plowmaster]

$BWVI .56, just saying more green and looks great, go do the DD!

[aljafy]

$VHUB Robert Kropf shell, atty letter coming, Yield now, Pink coming. Kropf knows what he's doing with finding R/M candidates.

Float only 261K shares

[Plowmaster]

$BWVI $.50 now, well not a lot of posts on this board, but still lots of room to go and definitive coming still, just heating up!

Can't say I didn't mention it, my post story right here lol

[Plowmaster]

$BWVI Well now we almost double and its thiiiiiin up top. When you have a crazy low 70M OS and low low 25M float just not much selling and it just keeps rising!

[Plowmaster]

$BWVI up 40% since the announcement. It continues to do well while waiting for that final 8K to come in!

Just a matter of time. These guys have a history of success with it, thats all they do!

$BWVI

Going to be great:

Www.Psycheceutical.com

[Plowmaster]

$BWVI Boom! CoC Filing Already out!!!

https://www.otcmarkets.com/otcapi/company/financial-report/309560/content

This Train is running fast!!!

Looking forward to the RM!!!

The goal of this disclosure is to provide information with respect to a company’s Change of Control event. Please address each of the below items to the best of the company’s ability and to the extent
they are applicable to the company’s Change of Control event.

Disclosure of Change in Control and Other Material Events:

1. A description of event(s) and relevant date(s) resulting in the Change in Control. Effective September 30, 2021, the two members of the board of directors of Blue Water Ventures International, Inc. (the "Company"), Larry Hoogendoorn and W. Keith Webb, resigned and Bruce Cassidy and Roger Tichenor were appointed to the Company's board of directors to fill the two vacancies. Mr. Webb also tendered his resignation as the Company's Principal Executive Officer and Chief Executive Officer; and Elizabeth Webb tendered her resignation as the Company's Secretary and Treasurer. Both resignations were effective September 30, 2021. The Company filled the officer vacancies by appointing Roger Tichenor the Company's Principal Executive Officer, Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer, also effective September 30, 2021.

2. The name(s) of person(s) who acquired control and person(s) from whom control was assumed. For corporations or other business entities, please provide the name(s) of person(s) beneficially owning or controlling such corporations or entities.2 Also, effective September 30, 2021, W. Keith Webb sold 8,813,515 shares of common stock and 300 shares of Series A preferred stock (each 100 shares of which is convertible into 1% of the outstanding shares of common stock on a fully diluted basis) to each of Roger Tichenor and Jeffery Bahnsen in exchange for an aggregate amount of $100,000.

[Plowmaster]

$BWVI RM With Psycheceutical!!!

This is going to be one of the biggest RM otc plays seen in a long time. Do your DD, checks the names these are big dogs getting a great shell, but they are here for otc this is NQ bound!

https://psycheceutical.com/

Great technology:

https://psycheceutical.com/technology/

Forbes article:

https://www.forbes.com/sites/benjaminadams/2021/09/17/armed-with-two-patents-psycheceutical-plans-to-transform-psychedelic-drug-delivery/?sh=449fdedb2396

https://www.otcmarkets.com/stock/BWVI/news/Blue-Water-Ventures-International-Inc-Signs-Non-Binding-Letter-of-Intent-to-Acquire-Psycheceutical-Inc?id=328933

Blue Water Ventures International, Inc. Signs Non-Binding Letter of Intent to Acquire Psycheceutical, Inc.
Press Release | 11/03/2021
Miami, FL, Nov. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Blue Water Ventures International, (OTC: BWVI), has signed a non-binding letter of intent which contemplates a proposed acquisition of Psycheceutical, Inc. Following the closing of the anticipated acquisition, Psycheceutical would emerge as the surviving company with a name and symbol change to follow.

“The closing of this acquisition marks a pivotal event that will provide Psycheceutical with the opportunity to achieve its next level of corporate growth as we advance our promising psychedelic drug delivery technologies,” said Chad Harman, Psycheceutical CEO.

Completion of the transaction is subject to due diligence investigations by the relevant parties, the negotiation and execution of a definitive share exchange agreement, satisfaction of the conditions negotiated therein including the approval of the Company's Board of Directors, and the satisfaction of other customary closing conditions. There can be no assurance that a definitive agreement will be entered into or that the proposed transaction will be consummated. Further, readers are cautioned that those portions of the LOI that describe the proposed transaction, including the consideration to be issued therein, are non-binding.

About Psycheceutical, Inc.
Psycheceutical, Inc. is using cutting-edge delivery technologies to develop safe and effective psychedelic pharmaceutical medicines. Powered by a team with more than 100 years' combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. Psycheceutical is on a mission to bring safety and efficacy to psychedelic compounds. Learn more at Psycheceutical.com.

Forward-Looking Statements
This press release contains forward-looking statements. Statements in this press release that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, references to business and development plans. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this press release, and Blue Water Ventures International assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents filed with available at www.otcmarkets.com.

Contact:

BWVI Investor Relations

Roger Tichenor, CEO

[e-mail]

[phone]

Psycheceutical, Inc. Investor Relations

Michael Hlavsa, CFO

[e-mail]

[phone]

Kaia Roman, VP, Strategy & Communications

[e-mail]

[phone]

[Plowmaster]

EPIC REVERSE MERGER JUST ANNOUNCED 2 MINUTES AGO! BWVI!!!!!

With Psycheceutical!!!

https://psycheceutical.com/

https://www.otcmarkets.com/stock/BWVI/news/Blue-Water-Ventures-International-Inc-Signs-Non-Binding-Letter-of-Intent-to-Acquire-Psycheceutical-Inc?id=328933

Blue Water Ventures International, Inc. Signs Non-Binding Letter of Intent to Acquire Psycheceutical, Inc.
Press Release | 11/03/2021
Miami, FL, Nov. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Blue Water Ventures International, (OTC: BWVI), has signed a non-binding letter of intent which contemplates a proposed acquisition of Psycheceutical, Inc. Following the closing of the anticipated acquisition, Psycheceutical would emerge as the surviving company with a name and symbol change to follow.

“The closing of this acquisition marks a pivotal event that will provide Psycheceutical with the opportunity to achieve its next level of corporate growth as we advance our promising psychedelic drug delivery technologies,” said Chad Harman, Psycheceutical CEO.

Completion of the transaction is subject to due diligence investigations by the relevant parties, the negotiation and execution of a definitive share exchange agreement, satisfaction of the conditions negotiated therein including the approval of the Company's Board of Directors, and the satisfaction of other customary closing conditions. There can be no assurance that a definitive agreement will be entered into or that the proposed transaction will be consummated. Further, readers are cautioned that those portions of the LOI that describe the proposed transaction, including the consideration to be issued therein, are non-binding.

About Psycheceutical, Inc.
Psycheceutical, Inc. is using cutting-edge delivery technologies to develop safe and effective psychedelic pharmaceutical medicines. Powered by a team with more than 100 years' combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. Psycheceutical is on a mission to bring safety and efficacy to psychedelic compounds. Learn more at Psycheceutical.com.

Forward-Looking Statements
This press release contains forward-looking statements. Statements in this press release that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, references to business and development plans. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this press release, and Blue Water Ventures International assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents filed with available at www.otcmarkets.com.

Contact:

BWVI Investor Relations

Roger Tichenor, CEO

[e-mail]

[phone]

Psycheceutical, Inc. Investor Relations

Michael Hlavsa, CFO

[e-mail]

[phone]

Kaia Roman, VP, Strategy & Communications

[e-mail]

[phone]

[aljafy]

BATON ROUGE, LA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Rogue Station Companies, Inc. (OTCMkts: RGST) announced today it has executed a business combination LOI with Everdime Technology, Inc., a multi-disciplinary cryptocurrency technology innovator, with a current emphasis on use of tokens and NFTs to monetize social networks for operators and participants. Its principals have developed technologies and a suite of applications that provide infrastructure for the generation of Fan Tokens and NFTs using the ERC20 blockchain, providing a safe, secure, and effective method for users to create, buy, and trade NFTs and cryptocurrencies.

John Conroy, CEO of RGST, expressed his excitement about future growth opportunities. “Everdime checks all the boxes for an ideal combination candidate for RGST. The company is positioned in an exploding industry and has a well-defined Business Plan and experienced management team.”

Sandor Miklos, CEO of Everdime Technologies, Inc stated, “Everdime is on the cutting edge of one of the fastest growing segments within the crypto space and RGST offers the public vehicle necessary to accomplish the expansion opportunities of the company. Our mission is to be a catalyst for faster crypto adoption by removing the barriers to the crypto revolution and empowering our users with an easy-to-use platform which diversifies and grows their portfolio while minimizing risk and maximizing reward on their investments.” Everdime is domiciled in Sheridan, Wyoming and operates out of Ontario, Canada.

Market analysts note that Blockchain adoption is still in its infancy, just as the internet was in its early years. The cryptocurrency industry has grown in the past five years, recently surpassing the $2 trillion market value. With just 130 million Bitcoin users globally, this compares to the internet's adoption rate in 1997, when many believed it would be a fad. Cryptocurrency-enabled currencies, including user-sponsored Fan Tokens and NFTs, are reshaping the future of finance and changing the way value is recognized, stored, transferred, and spent.

ABOUT THE COMPANIES

Rogue Station Companies, Inc. is a Delaware corporation that conducts business from Baton Rouge, Louisiana. It is currently a “shell” company, seeking an acquisition target that has an expandable business model and secured funding. Information about the Company can be obtained at otcmarkets.com. Everdime Technologies, Inc. is a Wyoming corporation that conducts business from Ontario, Canada. Information about the company can be obtained at everdime.com.

SAFE HARBOR STATEMENT

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports posted on ARS with OTC Markets Group, Inc. at www.otcmarkets.com. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

Contact: John Conroy, CEO
Corporate Services Rogue Station Companies, Inc.
225-273-1100

[silvermintz]

Just a heads up, Carey Cooley/Intl Venture ticker GYGC custodianship discharged. Only around $8M market cap (currently $17M) after 110M share cancellation reflected. New OS only 90M.

[aljafy]

RGST - Rogue Station Companies, Inc.
Company is current with no business. Current CEO and major owner John Conroy has kept this shell clean and does not allow toxic financing. He is looking for an ideal candidate.
Fillings on the otc are up to date - unchanged share structure for years. Float is below 5 million shares.
RGST SECURITY DETAILS
Share Structure

Market Cap Market Cap
2,133,779
09/20/2021
Authorized Shares
250,000,000
09/16/2021
Outstanding Shares
31,379,098
09/16/2021
Restricted
25,953,098
09/16/2021
Unrestricted
5,426,000
09/16/2021
Held at DTC
Not Available

Float
4,924,584
12/31/2020
Par Value
0.0001

Last updated - 09/21/2021